1996
DOI: 10.1002/(sici)1099-1352(199634/12)9:5/6<536::aid-jmr297>3.0.co;2-s
|View full text |Cite
|
Sign up to set email alerts
|

in vivo targeting of colloidal carriers by novel graft copolymers

Abstract: One of the major obstacles to the targeted delivery of colloidal carriers (nanocapsules) is the body's own defence mechanism in capturing foreign particles by the reticuloendothelial system (RES). This means that following intravenous administration, practically all nanometer size particles are captured by the RES (mainly the liver). This paper draws attention to a recent initiative on the design of 'macromolecular homing devices' which seem to disguise nanoparticles from the RES, and hence are of potential in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2006
2006
2008
2008

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…For example, the bulk PEG hydrogels are unable to respond to external temperature stimulations, whereas our PNIPAAm nanoparticle hydrogel networks can. In addition, nanoparticles have difficulty in reaching the target sites and a short time in circulating after the delivery due to the rapidly removal of the reticuloendothelial system (RES) as found in several studies (42–45). PNIPAAm nanoparticles also react quickly to an external stimulus and are too small for some practical applications (39).…”
Section: Discussionmentioning
confidence: 99%
“…For example, the bulk PEG hydrogels are unable to respond to external temperature stimulations, whereas our PNIPAAm nanoparticle hydrogel networks can. In addition, nanoparticles have difficulty in reaching the target sites and a short time in circulating after the delivery due to the rapidly removal of the reticuloendothelial system (RES) as found in several studies (42–45). PNIPAAm nanoparticles also react quickly to an external stimulus and are too small for some practical applications (39).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, we used the emulsific-aggregation method to prepare the biodegradable albendazole-polybutyl cyanocrylate nanoparticle(ABZ-PBCA-NP), butyl cyanocrylate (BCA) as the polymeric monomer. Animal studies suggest that nanoparticle can significantly improve abendazole bioavailability and hepatic target ability [6]. For albendazole nanoparticle's notable dispersibility and unsteability of aggregation and sedimentation, we studied the drug-load mechanism of albendazole polybutylcyanocrylate with isotherm-adsorption method; determined the aggregation dynamics though conductance and selected suitable assistant suspension to improve physical stability.…”
Section: Intruductionmentioning
confidence: 99%
“…In vivo, if the particle diameter of the nanoparticles is less than 200nm, it can be captured by reticuloendothelial system, especially by the Kupffer cell in the liver. In this paper [6], we employed the ABZ as the basic remedy, and butycyanocrylate (BCA) as the drug carrier to prepare the albendazole polybutylcyanoacrylate nanoparticles (ABZ-PBCA-NP) and albendazole polyvinyl pyrrolidone polybutylcyanoacrylate nanoparticles (PVP-ABZ-PBCA-NP),…”
Section: Introductionmentioning
confidence: 99%